2-Benzyl-2,5-diazabicyclo[2.2.1]heptane

Catalog No.: 
ACPOTE713
CAS No.: 
114086-14-5
Molecular Formula: 
C12H16N2
Molecular Weight: 
188.27
2-Benzyl-2,5-diazabicyclo[2.2.1]heptane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$597.00InquiryInquiry
250mg97%$1082.00InquiryInquiry
1g97%$2165.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Benzyl-2,5-diazabicyclo[2.2.1]heptane
IUPAC Name2-benzyl-2,5-diazabicyclo[2.2.1]heptane
MDL No.MFCD08694084
Molecular FormulaC12H16N2
Molecular Weight188.27
SMILESC1(C2)N(CC3=CC=CC=C3)CC2NC1
InChI KeyJPRFUVVWNBBEDI-UHFFFAOYSA-N
Synonym2-BENZYL-2,5-DIAZA-BICYCLO[2,2,1]HEPTANE;2,5-Diazabicyclo[2.2.1]heptane,2-(phenylmethyl)-(9CI);2-BENZYL-2,5-DIAZABICYCLO[2,2,1]HEPTANE,98%;2-(phenylmethyl)-2,5-diazabicyclo[2.2.1]heptane;(1R)-2-benzyl-2,5-diazabicyclo [2.2.1]heptane;2,5-Diazabicyclo[2.2.1]heptane, 2-(phenylmethyl)-
CAS No.114086-14-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPOTE713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPOTE713 route product structure diagram
    ACPOTE713114086-14-5
Inquiry

2. ACPOTE713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPOTE713 route product structure diagram
    ACPOTE713114086-14-5
Inquiry

3. ACPOTE713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPOTE713 route product structure diagram
    ACPOTE713114086-14-5
Inquiry

Comments (0)